Back to Journals » OncoTargets and Therapy » Volume 4

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

Total article views   HTML views PDF downloads Totals
13,062 Dovepress* 10,757+ 1,737 12,494
PubMed Central* 2,305 628 2,933
Totals 13,062 2,365 15,427
*Since 14 November 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar